Tag Archives: AMGN

Healthcare Sector Quick Highlights: Elan (NYSE:ELN), Amgen (NASDAQ:AMGN) – ELN, AMGN, PFE, ENDP, DVAX, SCLN

Posted on February 26, 2013 by Thomas Vedder

Investors responded negatively to the Healthcare stocks on Monday. Key movement were observed in Endo Health Solutions Inc (NASDAQ:ENDP) on percentage gainers side while Dynavax Technologies Corporation (NASDAQ:DVAX) and SciClone Pharmaceuticals, Inc (NASDAQ:SCLN) were major prominent decliners.

Royalty Pharma Management …

Posted in Healthcare, Latest Headlines | Tagged Amgen, AMGN, DVAX, Dynavax Technologies, Elan, ELN, Endo Health Solutions, ENDP, NASDAQ:AMGN, NASDAQ:DVAX, NASDAQ:ENDP, NASDAQ:SCLN, NYSE:ELN, NYSE:PFE, PFE, Pfizer, SciClone, SCLN | Comments Off

Decade Sunshine Decides to Acquire 3SBio (NASDAQ:SSRX) in $340 Million Deal – SSRX, AMGN, NVS, MRK

Posted on February 11, 2013 by Geoff Noir

3SBio Inc (ADR) (NASDAQ:SSRX) reported that it decided to be acquired by Decade Sunshine Ltd for almost $340 million.

Chinese biotechnology firm’s bid of $15.40 per American Depositary Shares is at a premium of around 12% to the ADS’s Thursday …

Posted in Healthcare, Latest Headlines | Tagged 3sBio, Amgen, AMGN, Merck, MRK, NASDAQ:AMGN, NASDAQ:SSRX, Novartis AG, NVS, NYSE:MRK, NYSE:NVS, SSRX | Comments Off

Healthcare Sector Tumbles; Keryx Biopharmaceuticals (KERX) Adds Nearly Double in Market Value while Johnson & Johnson (JNJ) Failed Own Safety Test – KERX, JNJ, PFE, SNSS, AMGN

Posted on January 29, 2013 by Thomas Vedder

Monday’s trading session data showed that healthcare sector reacted negatively with 0.36% change. Keryx Biopharmaceuticals (NASDAQ:KERX) and Sunesis Pharmaceuticals, Inc (NASDAQ:SNSS) were major gainer in this sector while most active stock was Amgen, Inc (NASDAQ:AMGN).

Keryx Biopharmaceuticals Inc (KERX) nearly …

Posted in Healthcare, Latest Headlines | Tagged Amgen, AMGN, JNJ, Johnson, KERX, Keryx Biopharmaceuticals, NASDAQ:AMGN, NASDAQ:KERX, Nasdaq:SNSS, NYSE:JNJ, NYSE:PFE, PFE, Pfizer, SNSS, Sunesis Pharmaceuticals | Comments Off

Amgen Inc. (NASDAQ:AMGN) Declares Optimistic Results of Colorectal Cancer – AMGN, UNH, DNDN, GNBT, BSX, BMY, HLF, JNJ, NVS

Posted on January 28, 2013 by Thomas Vedder

Amgen Inc. (NASDAQ:AMGN) announced that results from a late-stage study of its low white blood cell therapy Neulasta for patients with colorectal cancer were optimistic.

In a study assessing Neulasta in 845 patients getting chemotherapy therapies for colorectal cancer, the …

Posted in Healthcare, Latest Headlines | Tagged Amgen, AMGN, BMY, Boston Scientific, Bristol-Myers Squibb, BSX, Dendreon, DNDN, Generex Biotechnology, GNBT, Herbalife, HLF, JNJ, Johnson & Johnson, NASDAQ:AMGN, NASDAQ:DNDN, Novartis, NVS, NYSE:BMY, NYSE:BSX, NYSE:HLF, NYSE:JNJ, NYSE:NVS, NYSE:UNH, OTC:GNBT, UNH, UnitedHealth | Comments Off

ImmunoGen (NASDAQ:IMGN) Posts Wider than Expected Loss in Fiscal Q2; Stock Falls – IMGN, LLY, AMGN, SGEN

Posted on January 26, 2013 by Thomas Vedder

ImmunoGen, Inc (NASDAQ:IMGN) announced on Friday wider-than-projected loss for its fiscal Q2 mainly hurt by superior research and development costs.

The biotechnology company that develops anticancer products reported that revenues plunged sharply from previous year on the absence of previous …

Posted in Healthcare, Latest Headlines | Tagged Amgen, AMGN, Eli Lilly, IMGN, Immunogen, LLY, NASDAQ:AMGN, NASDAQ:IMGN, NASDAQ:SGEN, NYSE:LLY, Seattle Genetics, SGEN | Comments Off

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Working on Restructuring Plan, Hedging Jobs – BCRX, GSK, ARNA, UNH, CVM, HCA, VVUS, ABMD, AMGN

Posted on December 7, 2012 by Thomas Vedder

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)has decided to lay off 50% of its labor force as an element of a reformation program focused at lowering costs while progressing its antiviral program and its program for hereditary angioedema, an immune system disorder.

BioCryst–which …

Posted in Healthcare, Latest Headlines | Tagged ABIOMED, ABMD, Amgen, AMGN, arena, ARNA, BCRX, BioCryst Pharmaceuticals, CEL-SCI, CVM, GlaxoSmithKline, GSK, HCA, NASDAQ:ABMD, NASDAQ:AMGN, NASDAQ:ARNA, NASDAQ:BCRX, NASDAQ:VVUS, NYSE:GSK, NYSE:HCA, NYSE:UNH, NYSEAMEX:CVM, UNH, UnitedHealth, Vivus, VVUS | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.